The main goal of the Survey Research Core (SRC), located at the AMC Cancer Research Center, is to provide technical assistance and services to UCCC members in collecting research data, with specialized expertise in computer-assisted telephone interviews (CATI). The SRC collaborates in testing the effectiveness of cancer related health education and behavioral interventions delivered by telephone. Since its inception as a UCCC Core resource in the Year 2000, the SRC has shown sustained growth in utilization, providing support to 20 peer-reviewed cancer-related studies conducted by 12 different Principal Investigators affiliated with the UCCC. In these studies the SRC has conducted over 26,000 cancer-related telephone interviews. The number of cancer-related interviews completed by the SRC in Year 2004 exceeded 10,000, representing a 14-fold increase in utilization compared to the Year 2000. In the current operating budget the SRC gets 28% of its funding from the UCCC as a core resource, 55% from grants and contracts, and 17% from other UCCC institutional resources (Cancer Center gift funds and institutional support from AMC, a Consortium Cancer Center member institution). UCCC core funds provide partial support for consultation services, management, and oversight of this resource. All interviewer positions are 100% funded by grants and contracts. Future plans include: 1. expanding utilization of the SRC by UCCC members across a broader range of program areas (e.g. by using the SRC to conduct follow-up of patients in clinical trials) 2. using the SRC to test telephone education and counseling interventions across the full spectrum of cancer prevention and control 3. using the SRC to develop and test telephone-delivered patient navigation, support and referral interventions 4. expanding SRC capacity to conduct web-based surveys and interventions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046934-25S2
Application #
8710582
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
25
Fiscal Year
2013
Total Cost
$961
Indirect Cost
$339
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Roof, Allyson K; Jirawatnotai, Siwanon; Trudeau, Tammy et al. (2018) The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine. Endocrinology 159:2421-2434
McCubbrey, Alexandra L; Barthel, Lea; Mohning, Michael P et al. (2018) Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis. Am J Respir Cell Mol Biol 58:66-78
Fitzpatrick, Rikki L; Quimby, Jessica M; Benson, Kellyi K et al. (2018) In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease. J Vet Intern Med 32:1951-1957
Lee, Kyubum; Kim, Byounggun; Choi, Yonghwa et al. (2018) Deep learning of mutation-gene-drug relations from the literature. BMC Bioinformatics 19:21
Johnson, Monica; Alsaleh, Nasser; Mendoza, Ryan P et al. (2018) Genomic and transcriptomic comparison of allergen and silver nanoparticle-induced mast cell degranulation reveals novel non-immunoglobulin E mediated mechanisms. PLoS One 13:e0193499
Kimball, Abigail K; Oko, Lauren M; Bullock, Bonnie L et al. (2018) A Beginner's Guide to Analyzing and Visualizing Mass Cytometry Data. J Immunol 200:3-22
Parrish, Janet K; McCann, Tyler S; Sechler, Marybeth et al. (2018) The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth. Oncotarget 9:33110-33123
Herbst, Roy S; Redman, Mary W; Kim, Edward S et al. (2018) Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study. Lancet Oncol 19:101-114
Giles, Erin D; Jindal, Sonali; Wellberg, Elizabeth A et al. (2018) Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer. Breast Cancer Res 20:50
Nemkov, Travis; Sun, Kaiqi; Reisz, Julie A et al. (2018) Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Haematologica 103:361-372

Showing the most recent 10 out of 1634 publications